Levetiracetam 100 MG/ML Oral Solution — RxCUI 403884
RxNorm drug concept · Semantic clinical drug
RxCUI 403884
Semantic clinical drug · SCD
● Current RxNorm concept 35 FDA products
56 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI403884
Official nameLevetiracetam 100 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslevetiracetam 100 MG per 1 ML Oral Solution; levETIRAcetam 100 MG in 1 mL Oral Solution; levetiracetam 1000 MG per 10 ML Oral Solution; levetiracetam 1500 MG per 15 ML Oral Solution; levetiracetam 500 MG per 5 ML Oral Solution
FDA products mapped35
Package NDCs mapped56
Reported Medicaid activity (SDUD)824,531 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Levetiracetam: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats seizures in epilepsy. Depending on the product, that means partial-onset seizures, and as add-on therapy, myoclonic seizures in juvenile myoclonic epilepsy and primary ge...
- Follow your prescriber and label. Tablets and solution are usually twice daily, while extended-release tablets are once daily and must be swallowed whole. Use a calibrated device f...
- Sleepiness, tiredness, dizziness and headache are common, especially early on. Children may become irritable or aggressive. Avoid driving until you know how it affects you.
- Call right away for new or worsening depression, suicidal thoughts, unusual behavior, a rash, swelling of the face or throat, or trouble walking. Get emergency help for trouble bre...
🕸️ Concept Web — How Levetiracetam 100 MG/ML Oral Solution Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Levetiracetam 100 MG/ML Oral Solution
RxCUI 403884 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Levetiracetam
114477IN
-
Levetiracetam
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Keppra
261547BN
-
Keppra
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Levetiracetam Oral Solution
406121SCDF -
Levetiracetam Oral Liquid Product
1163450SCDG -
Levetiracetam Oral Product
1163451SCDG -
Levetiracetam Oral Solution [Keppra]
406093SBDF -
Keppra Oral Liquid Product
1170053SBDG -
Keppra Oral Product
1170054SBDG -
Oral Solution
316968DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Levetiracetam Oral Solution
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Levetiracetam 100 MG/ML
406092SCDC -
Levetiracetam 100 MG/ML Oral Solution [Keppra]
404595SBD -
Levetiracetam 100 MG/ML [Keppra]
576517SBDC
-
Levetiracetam 100 MG/ML
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Levetiracetam 100 MG/ML
SCDC · 406092 -
Levetiracetam Oral Solution
SCDF · 406121 -
Levetiracetam Oral Liquid Product
SCDG · 1163450 -
Levetiracetam Oral Product
SCDG · 1163451
Brand-Name Concepts
-
Levetiracetam 100 MG/ML Oral Solution [Keppra]
SBD · 404595 -
Levetiracetam 100 MG/ML [Keppra]
SBDC · 576517 -
Levetiracetam Oral Solution [Keppra]
SBDF · 406093 -
Keppra Oral Liquid Product
SBDG · 1170053 -
Keppra Oral Product
SBDG · 1170054 -
Keppra
BN · 261547
📦 FDA Products & Package NDCs
35 products · 56 package NDCs
56 package NDCs map to RxCUI 403884 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00121-0799-16 | 473 mL in 1 BOTTLE (0121-0799-16) | Levetiracetam | PAI Holdings, LLC dba PAI Pharma | 2015-06-04 |
| 00121-1598-20 | 2 TRAY in 1 CASE (0121-1598-20) / 10 CUP, UNIT-DOSE in 1 TR... | Levetiracetam | PAI Holdings, LLC dba PAI Pharma | 2022-10-10 |
| 00121-1598-40 | 4 TRAY in 1 CASE (0121-1598-40) / 10 CUP, UNIT-DOSE in 1 TR... | Levetiracetam | PAI Holdings, LLC dba PAI Pharma | 2015-06-04 |
| 00121-2397-40 | 4 TRAY in 1 CASE (0121-2397-40) / 10 CUP, UNIT-DOSE in 1 TR... | Levetiracetam | PAI Holdings, LLC dba PAI Pharma | 2015-06-04 |
| 00121-4799-40 | 4 TRAY in 1 CASE (0121-4799-40) / 10 CUP, UNIT-DOSE in 1 TR... | Levetiracetam | PAI Holdings, LLC dba PAI Pharma | 2015-06-04 |
| 00121-4799-50 | 5 TRAY in 1 CASE (0121-4799-50) / 10 CUP, UNIT-DOSE in 1 TR... | Levetiracetam | PAI Holdings, LLC dba PAI Pharma | 2020-05-28 |
| 00472-0235-16 | 473 mL in 1 BOTTLE, PLASTIC (0472-0235-16) | Levetiracetam | Actavis Pharma, Inc. | 2009-01-15 |
| 00904-7265-92 | 5 TRAY in 1 CASE (0904-7265-92) / 10 CUP, UNIT-DOSE in 1 TR... | Levetiracetam | Major Pharmaceuticals | 2022-11-21 |
| 00904-7265-93 | 3 TRAY in 1 CASE (0904-7265-93) / 10 CUP, UNIT-DOSE in 1 TR... | Levetiracetam | Major Pharmaceuticals | 2022-11-21 |
| 00904-7265-94 | 4 TRAY in 1 CASE (0904-7265-94) / 10 CUP, UNIT-DOSE in 1 TR... | Levetiracetam | Major Pharmaceuticals | 2022-11-21 |
| 00904-7420-16 | 473 mL in 1 BOTTLE, PLASTIC (0904-7420-16) | levetiracetam | MAJOR PHARMACEUTICALS | 2024-01-05 |
| 16714-0358-01 | 473 mL in 1 BOTTLE, PLASTIC (16714-358-01) | Levetiracetam | NorthStar Rx LLC | 2009-01-15 |
| 17856-0574-01 | 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0574-1) / 5 mL... | Levetiracetam Levetiracetam | Atlantic Biologicals Corp. | 2021-08-25 |
| 31722-0574-47 | 473 mL in 1 BOTTLE (31722-574-47) | Levetiracetam | Camber Pharmaceuticals, Inc. | 2015-06-11 |
| 39328-0511-05 | 5 mL in 1 CUP, UNIT-DOSE (39328-511-05) | Levetiracetam | Patrin Pharma, Inc. | 2024-01-31 |
| 39328-0511-30 | 3 TRAY in 1 CASE (39328-511-30) / 10 CUP, UNIT-DOSE in 1 TR... | Levetiracetam | Patrin Pharma, Inc. | 2024-01-31 |
| 39328-0511-40 | 4 TRAY in 1 CASE (39328-511-40) / 10 CUP, UNIT-DOSE in 1 TR... | Levetiracetam | Patrin Pharma, Inc. | 2024-01-31 |
| 39328-0511-50 | 5 TRAY in 1 CASE (39328-511-50) / 10 CUP, UNIT-DOSE in 1 TR... | Levetiracetam | Patrin Pharma, Inc. | 2024-01-31 |
| 50474-0001-48 | 473 mL in 1 BOTTLE, PLASTIC (50474-001-48) | Keppra | UCB, Inc. | 2003-10-20 |
| 50474-0594-40 | 120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50474-594-40) | Keppra | UCB, Inc. | 2000-04-24 |
| 50474-0595-40 | 120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50474-595-40) | Keppra | UCB, Inc. | 2000-04-24 |
| 50474-0596-40 | 120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50474-596-40) | Keppra | UCB, Inc. | 2000-04-24 |
| 50474-0597-66 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50474-597-66) | Keppra | UCB, Inc. | 2000-04-24 |
| 51672-4136-00 | 3785 mL in 1 BOTTLE (51672-4136-0) | Levetiracetam | Sun Pharmaceutical Industries, Inc. | 2009-02-10 |
| 51672-4136-07 | 100 mL in 1 BOTTLE (51672-4136-7) | Levetiracetam | Sun Pharmaceutical Industries, Inc. | 2009-02-10 |
| 51672-4136-09 | 473 mL in 1 BOTTLE (51672-4136-9) | Levetiracetam | Sun Pharmaceutical Industries, Inc. | 2009-02-10 |
| 53041-0660-06 | 473 mL in 1 BOTTLE (53041-660-06) | Levetiracetam | Guardian Drug Company | 2025-12-02 |
| 55154-4316-05 | 5 CUP, UNIT-DOSE in 1 BAG (55154-4316-5) / 5 mL in 1 CUP, U... | Levetiracetam | Cardinal Health 107, LLC | 2023-08-01 |
| 55154-5782-05 | 5 CUP, UNIT-DOSE in 1 BAG (55154-5782-5) / 5 mL in 1 CUP, U... | Levetiracetam | Cardinal Health 107, LLC | 2015-06-04 |
| 60687-0249-67 | 5 TRAY in 1 CASE (60687-249-67) / 10 CUP, UNIT-DOSE in 1 TR... | Levetiracetam | American Health Packaging | 2017-11-29 |
| 60687-0249-77 | 4 TRAY in 1 CASE (60687-249-77) / 10 CUP, UNIT-DOSE in 1 TR... | Levetiracetam | American Health Packaging | 2019-03-08 |
| 60687-0249-86 | 3 TRAY in 1 CASE (60687-249-86) / 10 CUP, UNIT-DOSE in 1 TR... | Levetiracetam | American Health Packaging | 2023-06-15 |
| 62135-0548-47 | 473 mL in 1 BOTTLE (62135-548-47) | LEVETIRACETAM solution | Chartwell RX, LLC | 2022-06-08 |
| 63629-9615-01 | 473 mL in 1 BOTTLE (63629-9615-1) | Levetiracetam | Bryant Ranch Prepack | 2023-02-03 |
| 65162-0685-86 | 118 mL in 1 BOTTLE (65162-685-86) | Levetiracetam | Amneal Pharmaceuticals LLC | 2009-10-27 |
| 65162-0685-90 | 473 mL in 1 BOTTLE (65162-685-90) | Levetiracetam | Amneal Pharmaceuticals LLC | 2009-10-27 |
| 65862-0250-05 | 500 mL in 1 BOTTLE, PLASTIC (65862-250-05) | Levetiracetam | Aurobindo Pharma Limited | 2009-01-15 |
| 65862-0250-47 | 473 mL in 1 BOTTLE, PLASTIC (65862-250-47) | Levetiracetam | Aurobindo Pharma Limited | 2009-01-15 |
| 68999-0548-24 | 2 TRAY in 1 BOX (68999-548-24) / 10 CUP in 1 TRAY / 5 mL in... | LEVETIRACETAM solution | Chartwell Governmental & Specialty RX, LLC. | 2025-10-29 |
| 69339-0157-17 | 40 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (69339-157-17) / 5 mL... | Levetiracetam | Natco Pharma USA LLC | 2021-01-31 |
| 69339-0157-19 | 100 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (69339-157-19) / 5 m... | Levetiracetam | Natco Pharma USA LLC | 2021-01-31 |
| 69452-0412-88 | 473 mL in 1 BOTTLE (69452-412-88) | LEVETIRACETAM | Bionpharma Inc. | 2024-07-18 |
| 70518-3803-00 | 10 CUP, UNIT-DOSE in 1 BOX (70518-3803-0) / 7.5 mL in 1 CUP... | Levetiracetam | REMEDYREPACK INC. | 2023-07-24 |
| 70518-3803-02 | 10 CUP, UNIT-DOSE in 1 BOX (70518-3803-2) / 5 mL in 1 CUP,... | Levetiracetam | REMEDYREPACK INC. | 2023-07-24 |
| 70518-3803-04 | 10 CUP, UNIT-DOSE in 1 BOX (70518-3803-4) / 12.5 mL in 1 CU... | Levetiracetam | REMEDYREPACK INC. | 2023-07-24 |
| 70518-3803-08 | 10 CUP, UNIT-DOSE in 1 BOX (70518-3803-8) / 15 mL in 1 CUP,... | Levetiracetam | REMEDYREPACK INC. | 2023-07-24 |
| 70518-3804-00 | 10 CUP, UNIT-DOSE in 1 BOX (70518-3804-0) / 10 mL in 1 CUP,... | Levetiracetam | REMEDYREPACK INC. | 2023-07-24 |
| 70518-3804-02 | 10 CUP, UNIT-DOSE in 1 BOX (70518-3804-2) / 25 mL in 1 CUP,... | Levetiracetam | REMEDYREPACK INC. | 2023-07-24 |
| 70752-0203-02 | 10 CUP, UNIT-DOSE in 1 TRAY (70752-203-02) / 15 mL in 1 CUP... | LEVETIRACETAM | QUAGEN PHARMACEUTICALS LLC | 2025-02-01 |
| 70752-0203-12 | 473 mL in 1 BOTTLE (70752-203-12) | LEVETIRACETAM | QUAGEN PHARMACEUTICALS LLC | 2025-02-01 |
Observed labelers:
PAI Holdings, LLC dba PAI Pharma (6) ·
REMEDYREPACK INC. (6) ·
UCB, Inc. (5) ·
MAJOR PHARMACEUTICALS (4) ·
Patrin Pharma, Inc. (4) ·
QUAGEN PHARMACEUTICALS LLC (4)
· +17 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.